FIT Biotech to publish H1/2015 Interim Report on August 31st, 2015 at 9.00 EET – FIT Biotech

Reports and Releases

FIT Biotech to publish H1/2015 Interim Report on August 31st, 2015 at 9.00 EET

Company release August 14th, 2015 at 08.30 EET

FIT Biotech to publish H1/2015 Interim Report on August 31st, 2015 at 9.00 EET

Fit Biotech Oy will publish Interim Report from the period January 1st - June 30th, 2015 on Monday 31st of August, 2015 at 9.00 EET.

FIT Biotech will inform the publishing date of the Financial Statements for 2015 in connection of the H1/2015 Interim Report.

FIT BIOTECH OY

Additional information:
CEO Kalevi Reijonen, FIT Biotech Oy Email: kalevi.reijonen@fitbiotech.com Phone: +358 40 843 5695

Certified Advisor: Translink Corporate Finance Oy, tel. +358 20 743 2790

FIT Biotech Oy in brief:
FIT Biotech Oy is a biotechnology company established in 1995, focusing on DNA vaccines and gene therapy. The company bases its products on its patented GTU ® (Gene Transport Unit) technology. Through GTU technology, FIT Biotech develops DNA vaccines in order to both prevent and also treat various diseases. Identified application areas include HIV, tuberculosis (and other infectious diseases) as well as gene therapy (cancer, autoimmune diseases). Other application areas are under development. FIT Biotech Oy is listed on NASDAQ First North (ticker: FITBIO). More information can be found at www.fitbiotech.com.

DISTRIBUTION:
NASDAQ OMX Helsinki
Principal media
www.fitbiotech.com

Back to list